期刊文献+

MicroRNA-199a-3p在肾癌中的表达及作用 被引量:8

The expression and significance of microRNA-199a-3p in renal cell carcinoma
下载PDF
导出
摘要 目的检测microRNA-199a-3p(miR-199a-3p)在肾癌细胞株和组织中的表达情况并探究miR-199a-3p在肾癌细胞中的作用。方法利用实时定量RT-PCR检测miR-199a-3p在肾癌细胞和组织中的表达水平;利用miR-199a-3p模拟物转染肾癌细胞786-0上调miR-199a-3p后,通过CCK-8、克隆形成、Transwell以及细胞周期检测来探究其在肾癌细胞中的作用。结果 miR-199a-3p在肾癌细胞中明显低表达,在78%(14/18)的肾癌组织中亦明显低表达;上调miR-199a-3p可显著抑制肾癌细胞的增殖、存活和侵袭并能诱导细胞周期G1期阻滞。结论我们的研究显示在肾癌中miR-199a-3p明显低表达并参与肾癌的发生、发展,这表明miR-199a-3p具有作为肾癌诊断和治疗靶点的潜能。 Objective To study the expression of microRNA-199a-3p (miR-199a-3p) in renal cell carcinoma (RCC) cell lines and tissues, and assess the impact of miR-199a-3p on the tumorigenesis of RCC. Methods miR-199a-3p levels in RCC cells and tissues were assessed by real-time qRT-PCR. The RCC cell line 786-0 was transfected with miR-199a-3p mimics to restore expression of miR-199a-3p. The effects of miR-199a-3p were then assessed by CCK-8, cell cycle, Transwell, and colony formation assay. Results We found that miR-199a-3p was remarkably downregulated in RCC cells and tissues. Restoration of miR-199a-3p dramatically suppressed RCC cells growth, clonability, invasion and induced G1-phase cell cycle arrest in vitro. Conclusions Collectively, these results demonstrated that miR-199a-3p was dramatically downregulated in RCC and involved in the etiology of RCC, which suggested that miR-199a-3p may offer an attractive new target for diagnostic and therapeutic intervention in RCC.
出处 《现代泌尿生殖肿瘤杂志》 2012年第4期229-232,241,共5页 Journal of Contemporary Urologic and Reproductive Oncology
基金 国家自然科学基金项目(81171963)
关键词 MicroRNA-199a-3p 抑癌基因 肾细胞癌 MicroRNA-199a-3p Tumor suppressor genes Renal cell carcinoma
  • 相关文献

参考文献13

  • 1White NM, Yousef GM. MicroRNAs: exploring a new di- mension in the pathogenesis of kidney cancer[J]. BMC Med, 2010,8:65.
  • 2van Spronsen DJ, de Weijer KJ, Mulders PF, et al. Novel treatment strategies in clear-cell metastatic renal cell careino- ma[J]. Anticancer Drugs,2005,16(7) :709-717.
  • 3Chow TF, Youssef YM, Lianidou E, et al. Differential ex- pression profiling of mieroRNAs and their potential involve- ment in renal cell carcinoma pathogenesis[J]. Clin Biochem, 2010,43(1-2) : 150-158.
  • 4Janzen NK, Kim HL, Figlin RA, et al. Surveillance after radical or partial nephrectomy for localized renal cell carcino- ma and management of recurrent disease[J]. Urol Clin North Am,2003,30(4) : 843-852.
  • 5Garzon R, Pichiorri F, Palumbo T, et al. MicroRNA gene expression during retinoic acid-induced differentiation of hu- man acute promyeloeytic Ieukeia[J]. Oncogene, 2007, 26 (28) :4148-4157.
  • 6Schickel R, Boyerinas B, Park SM, et al. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death[J]. Oncogene,2008,27(45) :5959-5974.
  • 7Shenouda SK, Alahari SK. MieroRNA function in cancer:oncogene or a tumor suppressor? [J]. Cancer Metastasis Rev,2009,28(3-4) :369-378.
  • 8Fornari F, Milazzo M, Chieco P, et al. MiR-199a-3p regu- lates roTOR and c-Met to influence the doxorubicin sensitivi- ty of human hepatocarcinoma cells[J]. Cancer Res, 2010,70 (12) :5184-5193.
  • 9Duan Z, Choy E, Harmon D, et al. MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell pro- liferation and migration[J]. Mol Cancer Ther, 2011,10 (8): 1337-1345.
  • 10Ichimi T, Enokida H, Okuno Y, et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer[J]. Int J Cancer,2009,125(2):345-352.

同被引文献65

  • 1劳明,朱波,黄玲莎,黄文成,李佩章,赵惠柳.三种肿瘤标志物联合检测对原发性肝癌的诊断价值[J].中华消化杂志,2005,25(2):109-110. 被引量:38
  • 2Bosch FX,Ribes J. Primary liver cancer: Worldwide incidence and trends[ J]. Gastroenterology,2004,127 ( 15 ) : s5-S16.
  • 3中国抗癌协会肝癌专业委员会.原发性肝癌规范化诊治专家共识[J].肿瘤防治研究,29(1):83-86.
  • 4Acunzo M, Romano G, Wemicke D,et al. MicroRNA and cancer-a brief overview[ J ]. Adv Biol Regul,2015,57 ( 3 ) : 1-9.
  • 5Yates LA, Norbury, C J, Gilbert ILl. The long and short of microRNA[ J]. Ce11,2013,153(3) :516-519.
  • 6Jiang L, Cbeng Q, Zhang BH. Circulating mieroRNAs as biomarkers in bepatocellular carcinoma screening:a validation set from China[ J~. Medicine (Baltimore) ,2015,94(10) :e603.
  • 7Hou J, Lin L, Zhou W,et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma [J], Cancer Cell, 2011,19(2) :232-243.
  • 8Bosch FX, Ribes J. Primary liver cancer: Worldwide incidence and trends [J]. Gastroenterology ,2004,127 ( 15 ).
  • 9Hou J,Lin L,Zhou W,et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma[ J]. Cancer Cell, 2011,19(2) :232-243.
  • 10Zhenfeng Duan, Edwin Choy, David Harmon, et al. microRNA- 199a-3p is downregulated in human osteosareoma and regulates cell proliferation and migration [ J ]. Molecular Cancer Therapeutics ,2011,10 ( 8 ) : 1337-1345.

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部